Beckley Psytech announces positive results for ELE-101 in depression trial
Phase 2a study shows promising antidepressant effects Beckley Psytech has announced positive topline results from its phase 2a study of...
adminph
Pharmaceutical Market Europe – December 2024 – PMLiVE
Pharmaceutical Market Europe – December 2024 PMLiVE
New drug shows promise against Duchenne muscular dystrophy
A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration....
Biopharma deals get smaller and earlier – Nature.com
Biopharma deals get smaller and earlier Nature.com
Breakthrough of the Year: A drug that prevents HIV infection, providing six months of protection per shot
As its 2024 Breakthrough of The Year, Science has named the development of lenacapavir - a promising new injectable drug...
Bayer begins inhibitor study treating advanced KRAS-mutated tumours
Trial explores potential of therapy in treating multiple cancer types Bayer has begun a phase 1 clinical trial for BAY3498264,...
Leriglitazone meets primary endpoint in pivotal cALD trial
Promising trial results support marketing authorisation application Minoryx Therapeutics and Neuraxpharm Group have announced that leriglitazone has met the primary...
Paracetamol may not be as safe as perceived in older people, according to a new study
New research, led by experts at the University of Nottingham, has found that repeated doses of paracetamol in people aged...
Trump names Andrew Ferguson as pick for FTC chair in potential win for biopharma dealmaking – FiercePharma
Trump names Andrew Ferguson as pick for FTC chair in potential win for biopharma dealmaking FiercePharma
iOnctura achieves new clinical milestones in uveal melanoma therapy
Successful phase 1 study highlights potential of roginolisib iOnctura has announced promising results from the phase 1 DIONE-01 study, showcasing...
Leriglitazone meets endpoint in trial for cerebral adrenoleukodystrophy
Promising results set stage for European marketing authorization Minoryx Therapeutics and Neuraxpharm Group have announced that leriglitazone met the primary...
Bayer acquires HiDoc Technologies and Cara Care® app for irritable bowel syndrome
Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to...
Cellenkos presents promising phase 1b data for CK0804 in myelofibrosis
New cell therapy shows potential in treating advanced blood disorder Cellenkos has unveiled new phase 1b data for its T-regulatory...
CatalYm shows potential of visugromab for treating cachexia
New findings presented at international SCWD conference CatalYm has announced promising new data on its lead drug candidate, visugromab, at...
New gene therapy reverses heart failure in large animal model
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model....
Imfinzi receives NICE recommendation for lung cancer treatment
Trial results lead to new treatment option for lung cancer AstraZeneca’s Imfinzi (durvalumab) in combination with chemotherapy has been recommended...
Poolbeg Pharma presents positive results for POLB 001
promising pre-clinical data on preventing cytokine release syndrome Poolbeg Pharma has unveiled encouraging pre-clinical study data for POLB 001 at...
Genetic code deploys cancer mafia, new targeted drug gives them an offer they can't refuse
A group of scientists at VCU Massey Comprehensive Cancer Center has revealed a new genetic code that acts like a...
A new method for efficient synthesis of anti-cancer drugs
The Horner-Wadsworth-Emmons (HWE) reaction is a fundamental reaction in organic chemistry, widely used to create conjugated carbonyl compounds. Conjugated carbonyl...
Teva’s Ajovy shows positive results in preventing pediatric migraines
Phase 3 trial indicates significant efficacy and safety for children and adolescents Teva Pharmaceutical Industries has presented positive data from...
